“…The nucleoside analog 5-aza-2 -deoxycytidine (5-aza-dC) is incorporated into the genome during DNA replication, inhibiting DNMT1 activity and resulting in DNA hypomethylation (Enright et al, 2003). Genomic DNA hypomethylation by 5-aza-dC treatment has been shown to improve the development of cloned embryos, whereas Dnmt1 or Dnmt3l knockdown in somatic cells or cloned embryos increases gene-specific DNA methylation and histone modification reprogramming and, consequently, developmental competence (Diao et al, 2013;Huan et al, 2015a;Liao et al, 2015;Song et al, 2017b). Additionally, the expression level of Tet3 in oocytes has been shown to be positively correlated with the developmental competence, and Tet3 overexpression in donor cells restores normal DNA hypermethylation and increases the full-term development of cloned embryos (Han et al, 2018).…”